How to Inactivate Human Ubiquitin E3 Ligases by Mutation

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• E3 ubiquitin ligases mediate ubiquitin transfer, crucial for protein fate.
• Defects in the ubiquitin-proteasome system are linked to numerous diseases.
• Inactivating E3 ligases is a key research area for understanding disease mechanisms.

Purpose of the Study:

• To compile and review site-specific inactivating mutations in human E3 ubiquitin ligases.
• To provide a resource for researchers studying E3 ligase function and dysfunction.
• To aid in the design of future experimental strategies targeting E3 ligases.

Main Methods:

• Literature review of over 250 site-specific inactivating mutations.
• Analysis of mutations affecting protein interaction, substrate recognition, or ubiquitin transfer.
• Focus on mutations in 120 distinct human E3 ubiquitin ligases.

Main Results:

• A comprehensive catalog of site-specific inactivating mutations for 120 human E3 ubiquitin ligases.
• Identification of key residues and mutation types that successfully inactivate E3 ligases.
• Demonstration that predicting inactivating mutations can be challenging.

Conclusions:

• This review consolidates valuable data on E3 ligase inactivating mutations.
• The compiled information serves as a foundation for future research on E3 ligase function and disease.
• Facilitates the rational design of experiments and therapeutic strategies involving E3 ligases.